TY - JOUR
T1 - Reducing umbilical catheter migration rates by using a novel securement device
AU - Perl, Juliana R.
AU - Crabtree-Beach, Tanya
AU - Olyaei, Amy
AU - Hedges, Madeline
AU - Jordan, Brian K.
AU - Scottoline, Brian
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Objective: This study evaluates the effectiveness of a novel device, LifeBubble, in reducing umbilical cord catheter (UC) migration and associated complications in neonates. Study design: A retrospective review was performed at Oregon Health & Science University’s NICU (2019–2021) to compare standard adhesive securement with LifeBubble. The primary outcomes were UC migration, discontinuation due to malposition, and CLABSI incidence. Differences between groups were statistically analyzed and logistic regression used to adjust for potential confounders. Results: Among 118 neonates (57 LifeBubble, 61 adhesive), LifeBubble significantly reduced migration of any UC > 1 vertebral body (12.3% vs. 55.7%), including UVC migration (5.3% vs. 39.3%) and UAC migration (7.0% vs 23.0%), as well as UVC discontinuation due to malposition (5.6% vs 37.7%). The number needed to treat (NNT) to prevent one instance of UVC discontinuation is 4. Conclusion: LifeBubble effectively reduces UC migration and premature discontinuation, indicating its potential to enhance neonatal care and safety.
AB - Objective: This study evaluates the effectiveness of a novel device, LifeBubble, in reducing umbilical cord catheter (UC) migration and associated complications in neonates. Study design: A retrospective review was performed at Oregon Health & Science University’s NICU (2019–2021) to compare standard adhesive securement with LifeBubble. The primary outcomes were UC migration, discontinuation due to malposition, and CLABSI incidence. Differences between groups were statistically analyzed and logistic regression used to adjust for potential confounders. Results: Among 118 neonates (57 LifeBubble, 61 adhesive), LifeBubble significantly reduced migration of any UC > 1 vertebral body (12.3% vs. 55.7%), including UVC migration (5.3% vs. 39.3%) and UAC migration (7.0% vs 23.0%), as well as UVC discontinuation due to malposition (5.6% vs 37.7%). The number needed to treat (NNT) to prevent one instance of UVC discontinuation is 4. Conclusion: LifeBubble effectively reduces UC migration and premature discontinuation, indicating its potential to enhance neonatal care and safety.
UR - http://www.scopus.com/inward/record.url?scp=85188465490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85188465490&partnerID=8YFLogxK
U2 - 10.1038/s41372-024-01943-1
DO - 10.1038/s41372-024-01943-1
M3 - Article
AN - SCOPUS:85188465490
SN - 0743-8346
JO - Journal of Perinatology
JF - Journal of Perinatology
ER -